Clinical Trial Diversity Strategies
 Making Health Equity a Reality for Underrepresented Populations via Multi-Stakeholder Collaboration and Solution-Driven Partnerships

February 10, 2021 | Live Virtual Forum (EST)

Melissa Gonzales

Inclusion Principal, External Partnering Genentech

Melissa received her PhD in Biochemistry from the University of Arizona. In 2006, she joined Genentech. During her 13 years with Genentech, Melissa has held a wide variety of positions including; Medical Science Liaison, Medical Science Director on HER2 Medical Teams, a Managed Care Liaison Field Manager, and most recently Inclusion Principal in the Chief Diversity Office. Melissa is focused on developing external partnering strategies to address health equity issues and ensure patients of color have access to clinical trials and quality care by Advancing Inclusive Research.

Event Program

12:15 PM Case Study: Implementing Diversity-Orientated Criteria & Metrics in Clinical Trial Design

From the implementation of technology to expand into underserved areas for clinical trials, to achieving c-suite buy-in to make diversity an organizational priority. Develop actionable strategies for trial planning, design and execution alongside, ideally, a diversity mandate within organizational strategy for clinical trials.